Summary:
A clinical research study is being conducted to learn if an investigational drug may help prevent Migraines. This study is 60 weeks long ( 4 weeks screening, 52 weeks treatment and 4 weeks safety follow-up), and it consists 16 visits to the Study Site
Qualified Participants Must:
• Be between 18-80
•
Have 4-14 migraine days per month
•
Have at least 1 year history of migraines
Qualified Participants May Receive:
Investigational drug & study exams at no cost
Compensation for time and travel.